Report Type : Therapy Reports
Report Category : Cardiovascular
Report Subcategory : Acute Coronary Syndrome
Price : 2999.00
Date : December 2021
Acute Coronary Syndrome : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Acute Coronary Syndrome
Acute coronary syndrome (ACS) is a condition in which there is reduced blood flow in the coronary arteries that leads to an improper function of part of the heart muscle. Acute Coronary Syndrome is further classified into (1) Non-ST-elevation myocardial infarction (NSTEMI), (2) ST-elevation MI (STEMI) and (3)Unstable angina.

Top 10 Companies:
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Pfizer Inc
Novartis AG
Merck & Co Inc
GlaxoSmithKline Plc
Sanofi
Bristol-Myers Squibb Co
AstraZeneca Plc
CSL Ltd